Sara Pai

Credentials: · · · · · ·

History

Cue-101 and TCR-T Cell Combinatorial Strategy for HPV+ Head and Neck Cancers
National Cancer Institute · R01
Contact PI · $2M · Yale University
2024–2029
Early Detection and Risk of Head and Neck Cancer Through Immune Based Spatial Omics
National Institute of Dental and Craniofacial Research · U01
Contact PI · $2.7M · Yale University
2023–2028
Strategies to Overcome Immune Resistance in Head and Neck Cancers
National Cancer Institute · P01
Contact PI · $8.4M · Yale University
2019–2026
FAST-FNA Immune Cell Profiling in HNSCC
National Cancer Institute · R01
PI · $2.6M · Massachusetts General Hospital
2021–2025

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
Principal investigator · Recruiting · Phase 2
Yale University
2026–2031
Merck IIT: RRP Pembro and Lenvatinib
Principal investigator · Recruiting · Phase 2
Yale University
2025–2027
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
Principal investigator · Recruiting
Massachusetts General Hospital
2024–2030
Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients
Principal investigator · Completed · Phase 1
Massachusetts General Hospital
2017–2024